About Avd. for Kreftbehandling, Oslo universitetssykehus
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Avd. for Kreftbehandling, Oslo universitetssykehus
During the past decade, Avd. for Kreftbehandling, Oslo universitetssykehus conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Avd. for Kreftbehandling, Oslo universitetssykehus"
#1 collaborator was "AstraZeneca" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Avd. for Kreftbehandling, Oslo universitetssykehus
According to Clinical.Site data, the most researched conditions in "Avd. for Kreftbehandling, Oslo universitetssykehus" are
"DLBCL" (1 trials), "Diffuse Large B Cell Lymphoma" (1 trials), "MCL" (1 trials) and "Mantle Cell Lymphoma" (1 trials). Many other conditions were trialed in "Avd. for Kreftbehandling, Oslo universitetssykehus" in a lesser frequency.
Clinical Trials Intervention Types at Avd. for Kreftbehandling, Oslo universitetssykehus
Most popular intervention types in "Avd. for Kreftbehandling, Oslo universitetssykehus" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Acalabrutinib-rituximab in patients with untreated mantle cell lymphoma" (1 trials), "R-mini-CHOP" (1 trials) and "R-pola-mini-CHP" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Avd. for Kreftbehandling, Oslo universitetssykehus
The vast majority of trials in "Avd. for Kreftbehandling, Oslo universitetssykehus" are
2 trials for "All" genders.
Clinical Trials Status at Avd. for Kreftbehandling, Oslo universitetssykehus
Currently, there are NaN active trials in "Avd. for Kreftbehandling, Oslo universitetssykehus".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Avd. for Kreftbehandling, Oslo universitetssykehus,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Avd. for Kreftbehandling, Oslo universitetssykehus, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".